Atellica IM High-Sensitivity Troponin I Assay is First in the U.S. to Include Prognostic Risk
Siemens Healthineers High-Sensitivity Troponin I (TnIH) can be used to aid in offering rapid and accurate detection of AMI helping lead to a faster diagnosisA and now also assists clinicians to help identify future cardiovascular event risk based on the new FDA-cleared prognostic risk claim extension
Proven, True High-Sensitivity Troponin I Assays
Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a critical role in the timely diagnosis of AMI, or heart attacks.
Siemens Healthineers offers proven, true high-sensitivity cardiac troponin I assays:
- Demonstrate clinical proof that the Siemens Healthineers’ assays are true high-sensitivity troponin I assays according to current guidelines.1-4
- Offer fast, accurate, and actionable results to leverage current protocols
- Provide confidence in results due to minimal assay interferences, including biotin*